Robust Control of a Brain-Persisting Parasite through MHC I Presentation by Infected Neurons.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
11 06 2019
Historique:
received: 10 09 2018
revised: 03 03 2019
accepted: 15 05 2019
entrez: 13 6 2019
pubmed: 13 6 2019
medline: 4 8 2020
Statut: ppublish

Résumé

Control of CNS pathogens by CD8 T cells is key to avoid fatal neuroinflammation. Yet, the modalities of MHC I presentation in the brain are poorly understood. Here, we analyze the antigen presentation mechanisms underlying CD8 T cell-mediated control of the Toxoplasma gondii parasite in the CNS. We show that MHC I presentation of an efficiently processed model antigen (GRA6-OVA), even when not expressed in the bradyzoite stage, reduces cyst burden and dampens encephalitis in C57BL/6 mice. Antigen presentation assays with infected primary neurons reveal a correlation between lower MHC I presentation of tachyzoite antigens by neurons and poor parasite control in vivo. Using conditional MHC I-deficient mice, we find that neuronal MHC I presentation is required for robust restriction of T. gondii in the CNS during chronic phase, showing the importance of MHC I presentation by CNS neurons in the control of a prevalent brain pathogen.

Identifiants

pubmed: 31189109
pii: S2211-1247(19)30680-1
doi: 10.1016/j.celrep.2019.05.051
pmc: PMC8908772
mid: NIHMS1613015
pii:
doi:

Substances chimiques

Antibodies, Protozoan 0
Antigens, Protozoan 0
GRA6 protein, Toxoplasma gondii 0
Histocompatibility Antigens Class I 0
Protozoan Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3254-3268.e8

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI065537
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI093132
Pays : United States

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Sci Rep. 2017 Aug 31;7(1):10170
pubmed: 28860577
Alzheimers Res Ther. 2017 Mar 4;9(1):14
pubmed: 28259169
J Neurosci. 2009 Dec 9;29(49):15397-409
pubmed: 20007464
Cell. 2018 Oct 4;175(2):458-471.e19
pubmed: 30173917
Brain. 2016 Nov 1;139(11):2923-2934
pubmed: 27604307
Immunity. 2016 Jul 19;45(1):159-71
pubmed: 27421704
Am J Pathol. 2010 Apr;176(4):1607-13
pubmed: 20167872
Int J Parasitol. 2004 Apr;34(5):543-8
pubmed: 15064118
Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):123-6
pubmed: 26421353
ASN Neuro. 2017 Jul-Aug;9(4):1759091417724915
pubmed: 28817954
J Neuroparasitology. 2010;1:
pubmed: 21625284
mBio. 2015 Sep 08;6(5):e01155-15
pubmed: 26350965
Infect Immun. 2013 Sep;81(9):3414-25
pubmed: 23817617
Am J Pathol. 2010 Oct;177(4):1823-33
pubmed: 20813972
Nature. 1982 Dec 23;300(5894):755-7
pubmed: 6184620
Nat Commun. 2018 Feb 12;9(1):633
pubmed: 29434238
Parasit Vectors. 2014 Aug 15;7:372
pubmed: 25128410
Eur J Immunol. 2017 Jul;47(7):1160-1170
pubmed: 28508576
Immunology. 1995 Jul;85(3):419-28
pubmed: 7558130
J Exp Med. 2013 Sep 23;210(10):2087-103
pubmed: 23999498
Afr Health Sci. 2016 Jun;16(2):603-10
pubmed: 27605978
J Exp Med. 2009 Apr 13;206(4):953-66
pubmed: 19349466
Neurobiol Dis. 2013 Nov;59:194-205
pubmed: 23899663
Nat Immunol. 2008 Aug;9(8):937-44
pubmed: 18587399
Trends Neurosci. 2012 Nov;35(11):660-70
pubmed: 22939644
J Exp Med. 1995 Nov 1;182(5):1201-12
pubmed: 7595191
Front Immunol. 2012 Nov 07;3:331
pubmed: 23162549
J Immunol. 1980 Dec;125(6):2473-7
pubmed: 7191868
Int J Parasitol. 2009 Oct;39(12):1385-94
pubmed: 19433092
J Immunol. 2019 Mar 15;202(6):1755-1766
pubmed: 30718297
Nat Commun. 2014 Apr 16;5:3633
pubmed: 24736453
Brain Res. 2013 Jun 26;1518:9-25
pubmed: 23632380
Genesis. 2001 Sep;31(1):37-42
pubmed: 11668676
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Neuron. 1998 Sep;21(3):505-20
pubmed: 9768838
Science. 2000 Dec 15;290(5499):2155-9
pubmed: 11118151
Parasite Immunol. 2015 Mar;37(3):150-8
pubmed: 25573476
J Immunol. 2015 Apr 1;194(7):3223-35
pubmed: 25710908
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10956-61
pubmed: 27621438
PLoS Pathog. 2013;9(6):e1003449
pubmed: 23818852
Immunity. 2017 Jun 20;46(6):891-909
pubmed: 28636958
Infect Immun. 2007 Apr;75(4):1626-34
pubmed: 17261600
Langmuir. 2018 Jun 5;34(22):6612-6620
pubmed: 29754481
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6020-4
pubmed: 1378619
Trends Immunol. 2015 Oct;36(10):637-650
pubmed: 26431941
Virchows Arch A Pathol Anat Histopathol. 1987;411(1):39-43
pubmed: 3107207
J Infect Dis. 2008 Dec 1;198(11):1625-33
pubmed: 18922097
Annu Rev Immunol. 2017 Apr 26;35:441-468
pubmed: 28226226
J Immunol. 2017 May 15;198(10):4054-4061
pubmed: 28389591
Neurobiol Aging. 2017 May;53:76-82
pubmed: 28235681
J Exp Med. 2015 Jul 27;212(8):1153-69
pubmed: 26122661
J Immunol. 2009 May 15;182(10):6379-93
pubmed: 19414791
Microbes Infect. 2006 May;8(6):1623-30
pubmed: 16697685
Emerg Infect Dis. 2003 Nov;9(11):1375-80
pubmed: 14725265
Parasite Immunol. 2017 Nov;39(11):
pubmed: 28881035
PLoS Pathog. 2011 Sep;7(9):e1002246
pubmed: 21949652
Foodborne Pathog Dis. 2016 Mar;13(3):109-18
pubmed: 26854596
J Immunol. 2015 Aug 1;195(3):796-800
pubmed: 26091720
Sci Rep. 2016 Mar 03;6:22551
pubmed: 26936108
PLoS Pathog. 2016 Feb 19;12(2):e1005447
pubmed: 26895155
PLoS Pathog. 2011 Nov;7(11):e1002393
pubmed: 22114563
mBio. 2016 Nov 8;7(6):
pubmed: 27834206
Front Cell Infect Microbiol. 2017 Jun 21;7:259
pubmed: 28680853
PLoS Pathog. 2015 Jul 23;11(7):e1004935
pubmed: 26203656
Eukaryot Cell. 2011 Sep;10(9):1193-206
pubmed: 21531875
Nat Neurosci. 2011 Apr;14(4):442-51
pubmed: 21358642
Brain Res. 2015 Oct 14;1623:63-73
pubmed: 25813828
Dis Model Mech. 2014 Apr;7(4):459-69
pubmed: 24524910
Acta Neuropathol Commun. 2016 Mar 16;4:25
pubmed: 26984535
Proc Natl Acad Sci U S A. 1983 Apr;80(7):2040-3
pubmed: 6188160
J Exp Med. 2016 Aug 22;213(9):1799-818
pubmed: 27481131

Auteurs

Anna Salvioni (A)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Marcy Belloy (M)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Aurore Lebourg (A)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Emilie Bassot (E)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Vincent Cantaloube-Ferrieu (V)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Virginie Vasseur (V)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Sophie Blanié (S)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Roland S Liblau (RS)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Elsa Suberbielle (E)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France.

Ellen A Robey (EA)

Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.

Nicolas Blanchard (N)

Center for Pathophysiology Toulouse-Purpan (CPTP), INSERM, CNRS, University of Toulouse, 31024 Toulouse, France. Electronic address: nicolas.blanchard@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH